Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Jan 23;14(1):8–20. doi: 10.1007/s11684-020-0739-z

Research progress on human infection with avian influenza H7N9

Xiaoxin Wu 1, Lanlan Xiao 1, Lanjuan Li 1,✉
PMCID: PMC7101792  PMID: 31989396

Abstract

Since the first case of novel H7N9 infection was reported, China has experienced five epidemics of H7N9. During the fifth wave, a highly pathogenic H7N9 strain emerged. Meanwhile, the H7N9 virus continues to accumulate mutations, and its affinity for the human respiratory epithelial sialic acid 2–6 receptor has increased. Therefore, a pandemic is still possible. In the past 6 years, we have accumulated rich experience in dealing with H7N9, especially in terms of virus tracing, epidemiological research, key site mutation monitoring, critical disease mechanisms, clinical treatment, and vaccine development. In the research fields above, significant progress has been made to effectively control the spread of the epidemic and reduce the fatality rate. To fully document the research progress concerning H7N9, we reviewed the clinical and epidemiological characteristics of H7N9, the key gene mutations of the virus, and H7N9 vaccine, thus providing a scientific basis for further monitoring and prevention of H7N9 influenza epidemics.

Electronic Supplementary Material

Supplementary material is available in the online version of this article at 10.1007/s11684-020-0739-z and is accessible for authorized users.

Keywords: H7N9, pandemic, epidemiology, mutations, vaccine, influenza

Electronic supplementary material

11684_2020_739_MOESM1_ESM.pdf (163.4KB, pdf)

Supplementary material, approximately 163 KB.

Acknowledgements

This work was supported by the State Project of Essential Drug Research and Development (No. 2015ZX09101044).

Compliance with ethics guidelines

Xiaoxin Wu, Lanlan Xiao, and Lanjuan Li declare that they have no financial conflicts of interest. This manuscript is a review article and does not require approval by a relevant institutional review board or ethics committee.

References

  • 1.Liu T, Kang M, Zhang B, Xiao J, Lin H, Zhao Y, Huang Z, Wang X, Zhang Y, He J, Ma W. Independent and interactive effects of ambient temperature and absolute humidity on the risks of avian influenza A(H7N9) infection in China. Sci Total Environ. 2018;619–620:1358–1365. doi: 10.1016/j.scitotenv.2017.11.226. [DOI] [PubMed] [Google Scholar]
  • 2.Skowronski DM, Chambers C, Gustafson R, Purych DB, Tang P, Bastien N, Krajden M, Li Y. Avian influenza A(H7N9) virus infection in 2 travelers returning from China to Canada, January 2015. Emerg Infect Dis. 2016;22(1):71–74. doi: 10.3201/eid2201.151330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.William T, Thevarajah B, Lee SF, Suleiman M, Jeffree MS, Menon J, Saat Z, Thayan R, Tambyah PA, Yeo TW. Avian influenza (H7N9) virus infection in Chinese tourist in Malaysia, 2014. Emerg Infect Dis. 2015;21(1):142–145. doi: 10.3201/eid2101.141092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Yao H, Wo J, Fang Q, Cui D, Li Y, Yao X, Zhang Y, Wu H, Zheng S, Diao H, Xia S, Zhang Y, Chan KH, Tsoi HW, Teng JL, Song W, Wang P, Lau SY, Zheng M, Chan JF, To KK, Chen H, Li L, Yuen KY. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet. 2013;381(9881):1916–1925. doi: 10.1016/S0140-6736(13)60903-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wang X, Jiang H, Wu P, Uyeki TM, Feng L, Lai S, Wang L, Huo X, Xu K, Chen E, Wang X, He J, Kang M, Zhang R, Zhang J, Wu J, Hu S, Zhang H, Liu X, Fu W, Ou J, Wu S, Qin Y, Zhang Z, Shi Y, Zhang J, Artois J, Fang VJ, Zhu H, Guan Y, Gilbert M, Horby PW, Leung GM, Gao GF, Cowling BJ, Yu H. Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013–17: an epidemiological study of laboratory-confirmed case series. Lancet Infect Dis. 2017;17(8):822–832. doi: 10.1016/S1473-3099(17)30323-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zhang F, Bi Y, Wang J, Wong G, Shi W, Hu F, Yang Y, Yang L, Deng X, Jiang S, He X, Liu Y, Yin C, Zhong N, Gao GF. Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China. J Infect. 2017;75(1):71–75. doi: 10.1016/j.jinf.2017.04.001. [DOI] [PubMed] [Google Scholar]
  • 7.Yang L, Zhu W, Li X, Chen M, Wu J, Yu P, Qi S, Huang Y, Shi W, Dong J, Zhao X, Huang W, Li Z, Zeng X, Bo H, Chen T, Chen W, Liu J, Zhang Y, Liang Z, Shi W, Shu Y, Wang D. Genesis and spread of newly emerged highly pathogenic H7N9 avian viruses in mainland China. J Virol. 2017;91(23):e01277–17. doi: 10.1128/JVI.01277-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Qi W, Jia W, Liu D, Li J, Bi Y, Xie S, Li B, Hu T, Du Y, Xing L, Zhang J, Zhang F, Wei X, Eden JS, Li H, Tian H, Li W, Su G, Lao G, Xu C, Xu B, Liu W, Zhang G, Ren T, Holmes EC, Cui J, Shi W, Gao GF, Liao M. Emergence and adaptation of a novel highly pathogenic H7N9 influenza virus in birds and humans from a 2013 human-infecting low-pathogenic ancestor. J Virol. 2018;92(2):e00921–17. doi: 10.1128/JVI.00921-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Iuliano AD, Jang Y, Jones J, Davis CT, Wentworth DE, Uyeki TM, Roguski K, Thompson MG, Gubareva L, Fry AM, Burns E, Trock S, Zhou S, Katz JM, Jernigan DB. Increase in human infections with avian influenza A(H7N9) virus during the fifth epidemic — China, October, 2016–February, 2017. MMWR Morb Mortal Wkly Rep. 2017;66(9):254–255. doi: 10.15585/mmwr.mm6609e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Shi J, Deng G, Ma S, Zeng X, Yin X, Li M, Zhang B, Cui P, Chen Y, Yang H, Wan X, Liu L, Chen P, Jiang Y, Guan Y, Liu J, Gu W, Han S, Song Y, Liang L, Qu Z, Hou Y, Wang X, Bao H, Tian G, Li Y, Jiang L, Li C, Chen H. Rapid evolution of H7N9 highly pathogenic viruses that emerged in China in 2017. Cell Host Microbe. 2018;24(4):558–568. doi: 10.1016/j.chom.2018.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Quan C, Shi W, Yang Y, Yang Y, Liu X, Xu W, Li H, Li J, Wang Q, Tong Z, Wong G, Zhang C, Ma S, Ma Z, Fu G, Zhang Z, Huang Y, Song H, Yang L, Liu WJ, Liu Y, Liu W, Gao GF, Bi Y. New threats from H7N9 influenza virus: spread and evolution of high- and low-pathogenicity variants with high genomic diversity in Wave Five. J Virol. 2018;92(11):e00301–18. doi: 10.1128/JVI.00301-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, Lu SH, Yang YD, Fang Q, Shen YZ, Xi XM, Gu Q, Zhou XM, Qu HP, Yan Z, Li FM, Zhao W, Gao ZC, Wang GF, Ruan LX, Wang WH, Ye J, Cao HF, Li XW, Zhang WH, Fang XC, He J, Liang WF, Xie J, Zeng M, Wu XZ, Li J, Xia Q, Jin ZC, Chen Q, Tang C, Zhang ZY, Hou BM, Feng ZX, Sheng JF, Zhong NS, Li LJ. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013;368(24):2277–2285. doi: 10.1056/NEJMoa1305584. [DOI] [PubMed] [Google Scholar]
  • 13.Sun HY, Tong JH, Cui DW, Chen Y. Research progress on human infection with avian influenza H7N9. Chin J Clin Infect Dis (Zhonghua Lin Chuang Gan Ran Bing Za Zhi) 2017;10(7):8. [Google Scholar]
  • 14.State Health and Family Planning Commission of the People’s Republic of China. Diagnosis and treatment Program for Human infection with H7N9 Avian Influenza (2014 Edition). 2014
  • 15.Yang MF. Clinical study on the early warning of the severe avian influenza H7N9. Hangzhou, Zhejiang, China: Zhejiang University School of Medicine; 2015. [Google Scholar]
  • 16.Jin C, Wu N, Peng X, Yao H, Lu X, Chen Y, Wu H, Xie T, Cheng L, Liu F, Kang K, Tang S, Li L. Comparison of a new gold immunochromatographic assay for the rapid diagnosis of the novel influenza A (H7N9) virus with cell culture and a real-time reverse-transcription PCR assay. BioMed Res Int. 2014;2014:425051. doi: 10.1155/2014/425051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Yu L, Wang Z, Chen Y, Ding W, Jia H, Chan JF, To KK, Chen H, Yang Y, Liang W, Zheng S, Yao H, Yang S, Cao H, Dai X, Zhao H, Li J, Bao Q, Chen P, Hou X, Li L, Yuen KY. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A (H7N9) virus. Clin Infect Dis. 2013;57(10):1449–1457. doi: 10.1093/cid/cit541. [DOI] [PubMed] [Google Scholar]
  • 18.Hu Y, Lu S, Song Z, Wang W, Hao P, Li J, Zhang X, Yen HL, Shi B, Li T, Guan W, Xu L, Liu Y, Wang S, Zhang X, Tian D, Zhu Z, He J, Huang K, Chen H, Zheng L, Li X, Ping J, Kang B, Xi X, Zha L, Li Y, Zhang Z, Peiris M, Yuan Z. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet. 2013;381(9885):2273–2279. doi: 10.1016/S0140-6736(13)61125-3. [DOI] [PubMed] [Google Scholar]
  • 19.Chen C, Chen J, Huang JA. Persistence of lymphocytopenia with CT abnormalities among patients with critical H7N9 swine-origin influenza A virus infection. Jpn J Radiol. 2015;33(10):657–662. doi: 10.1007/s11604-015-0476-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Huang JB, Li HY, Liu JF, Lan CQ, Lin QH, Chen SX, Zhang HY, Wang XH, Lin X, Pan JG, Weng H. Histopathological findings in a critically ill patient with avian influenza A (H7N9) J Thorac Dis. 2015;7(12):E672–E677. doi: 10.3978/j.issn.2072-1439.2015.11.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tsai NW, Ngai CW, Mok KL, Tsung JW. Lung ultrasound imaging in avian influenza A (H7N9) respiratory failure. Crit Ultrasound J. 2014;6(1):6. doi: 10.1186/2036-7902-6-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Yu H, Wu JT, Cowling BJ, Liao Q, Fang VJ, Zhou S, Wu P, Zhou H, Lau EH, Guo D, Ni MY, Peng Z, Feng L, Jiang H, Luo H, Li Q, Feng Z, Wang Y, Yang W, Leung GM. Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study. Lancet. 2014;383(9916):541–548. doi: 10.1016/S0140-6736(13)61904-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Wang J, Su N, Dong Z, Liu C, Cui P, Huang JA, Chen C, Zhu Y, Chen L. The fifth influenza A (H7N9) epidemic: a family cluster of infection in Suzhou City of China, 2016. Int J Infect Dis. 2018;74:128–135. doi: 10.1016/j.ijid.2018.04.4322. [DOI] [PubMed] [Google Scholar]
  • 24.Liu S, Sun J, Cai J, Miao Z, Lu M, Qin S, Wang X, Lv H, Yu Z, Amer S, Chai C. Epidemiological, clinical and viral characteristics of fatal cases of human avian influenza A (H7N9) virus in Zhejiang Province, China. J Infect. 2013;67(6):595–605. doi: 10.1016/j.jinf.2013.08.007. [DOI] [PubMed] [Google Scholar]
  • 25.Zheng S, Tang L, Gao H, Wang Y, Yu F, Cui D, Xie G, Yang X, Zhang W, Ye X, Zhang Z, Wang X, Yu L, Zhang Y, Yang S, Liang W, Chen Y, Li L. Benefit of early initiation of neuraminidase inhibitor treatment to hospitalized patients with avian influenza A (H7N9) virus. Clin Infect Dis. 2018;66(7):1054–1060. doi: 10.1093/cid/cix930. [DOI] [PubMed] [Google Scholar]
  • 26.Zhang Y, Gao H, Liang W, Tang L, Yang Y, Wu X, Yu L, Chen P, Zheng S, Ou H, Li L. Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for influenza A (H7N9) infection: a retrospective study. BMC Infect Dis. 2016;16(1):76. doi: 10.1186/s12879-016-1383-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Xi ZQ, Zhou XM, Wang X, Bing QL, Chang N, Guo T, Zhong J, Feng GZ, Huang XM. Severe analysis of human H7N9 avian influenza treated with traditional Chinese medicine. Jiangsu J Tradit Chin Med (Jiangsu Zhong Yi Yao Za Zhi) 2015;47(8):13–17. [Google Scholar]
  • 28.Luo X, Shen X, Hu BX. Studies on the anti-influenza virus H7N9 of honeysuckle and Forsythia suspensa based on molecular docking method. Modern Tradit Chin Med (Xian Dai Zhong Yi Yao) 2016;36(2):75–78. [Google Scholar]
  • 29.Liu X, Zhang Y, Xu X, Du W, Su K, Zhu C, Chen Y, Lei S, Zheng S, Jiang J, Yang S, Guo J, Shao L, Yang Q, Chen J, Li L. Evaluation of plasma exchange and continuous veno-venous hemofiltration for the treatment of severe avian influenza A (H7N9): a cohort study. Ther Apher Dial. 2015;19(2):178–184. doi: 10.1111/1744-9987.12240. [DOI] [PubMed] [Google Scholar]
  • 30.Yu WQ, Ding MD, Dai GH, Gu CJ, Xue L, Chen Y, Zhou DM, Xian JC, Xu HT. Analysis of 15 cases of avian influenza virus (H7N9) infection. Chin J Tuberc Respir Dis (Zhonghua Jie He He Hu Xi Za Zhi) 2018;41(7):534–538. doi: 10.3760/cma.j.issn.1001-0939.2018.07.006. [DOI] [PubMed] [Google Scholar]
  • 31.Huang L, Zhang W, Yang Y, Wu W, Lu W, Xue H, Zhao H, Wu Y, Shang J, Cai L, Liu L, Liu D, Wang Y, Cao B, Zhan Q, Wang C. Application of extracorporeal membrane oxygenation in patients with severe acute respiratory distress syndrome induced by avian influenza A (H7N9) viral pneumonia: national data from the Chinese multicentre collaboration. BMC Infect Dis. 2018;18(1):23. doi: 10.1186/s12879-017-2903-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Nie Q, Zhang DY, Wu WJ, Huang CL, Ni ZY. Extracorporeal membrane oxygenation for avian influenza A (H7N9) patient with acute respiratory distress syndrome: a case report and short literature review. BMC Pulm Med. 2017;17(1):38. doi: 10.1186/s12890-017-0381-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Qian L, Zheng J, Xu H, Shi L, Li L. Extracorporeal membrane oxygenation treatment of a H7N9-caused respiratory failure patient with mechanical valves replacement history: a case report. Medicine (Baltimore) 2016;95(40):e5052. doi: 10.1097/MD.0000000000005052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Wang G, Zhou Y, Gong S, Dong H, Wu G, Xiang X, Tang J. A pregnant woman with avian influenza A (H7N9) virus pneumonia and ARDS managed with extracorporeal membrane oxygenation. Southeast Asian J Trop Med Public Health. 2015;46(3):444–448. [PubMed] [Google Scholar]
  • 35.Tang X, He H, Sun B, Wan J, Ban C, Zhang C, Wang S, Xia J, Li J, Liu Y, Cao B, Tong Z. ARDS associated with pneumonia caused by avian influenza A H7N9 virus treated with extracorporeal membrane oxygenation. Clin Respir J. 2015;9(3):380–384. doi: 10.1111/crj.12140. [DOI] [PubMed] [Google Scholar]
  • 36.Liu C, Li J, Sun W, Yang R, Lu W, Gao D, Wu D. Extracorporeal membrane oxygenation as rescue therapy for H7N9 influenza-associated acute respiratory distress syndrome. Chin Med J (Engl) 2014;127(9):1798. [PubMed] [Google Scholar]
  • 37.Xi X, Fang Q, Gu Q, Du B, China Critical Care Clinical Trial Group CCCCTG Avian influenza A (H7N9) infections: intensivists as virus hunters in the new century. J Crit Care. 2013;28(4):528–530. doi: 10.1016/j.jcrc.2013.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Yang M, Gao H, Chen J, Xu X, Tang L, Yang Y, Liang W, Yu L, Sheng J, Li L. Bacterial coinfection is associated with severity of avian influenza A (H7N9), and procalcitonin is a useful marker for early diagnosis. Diagn Microbiol Infect Dis. 2016;84(2):165–169. doi: 10.1016/j.diagmicrobio.2015.10.018. [DOI] [PubMed] [Google Scholar]
  • 39.Qin N, Zheng B, Yao J, Guo L, Zuo J, Wu L, Zhou J, Liu L, Guo J, Ni S, Li A, Zhu Y, Liang W, Xiao Y, Ehrlich SD, Li L. Influence of H7N9 virus infection and associated treatment on human gut microbiota. Sci Rep. 2015;5(1):14771. doi: 10.1038/srep14771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Hu X, Zhang H, Lu H, Qian G, Lv L, Zhang C, Guo J, Jiang H, Zheng B, Yang F, Gu S, Chen Y, Bao Q, Yu L, Jiang X, Hu Q, Shi H, Gao H, Li L. The effect of probiotic treatment on patients infected with the H7N9 influenza virus. PLoS One. 2016;11(3):e0151976. doi: 10.1371/journal.pone.0151976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Lu H, Zhang C, Qian G, Hu X, Zhang H, Chen C, Liang W, Gao H, Yang Y, Li L. An analysis of microbiota-targeted therapies in patients with avian influenza virus subtype H7N9 infection. BMC Infect Dis. 2014;14(1):359. doi: 10.1186/1471-2334-14-359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Wang Z, Zhang A, Wan Y, Liu X, Qiu C, Xi X, Ren Y, Wang J, Dong Y, Bao M, Li L, Zhou M, Yuan S, Sun J, Zhu Z, Chen L, Li Q, Zhang Z, Zhang X, Lu S, Doherty PC, Kedzierska K, Xu J. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci USA. 2014;111(2):769–774. doi: 10.1073/pnas.1321748111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Guo J, Huang F, Liu J, Chen Y, Wang W, Cao B, Zou Z, Liu S, Pan J, Bao C, Zeng M, Xiao H, Gao H, Yang S, Zhao Y, Liu Q, Zhou H, Zhu J, Liu X, Liang W, Yang Y, Zheng S, Yang J, Diao H, Su K, Shao L, Cao H, Wu Y, Zhao M, Tan S, Li H, Xu X, Wang C, Zhang J, Wang L, Wang J, Xu J, Li D, Zhong N, Cao X, Gao GF, Li L, Jiang C. The serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes. Sci Rep. 2015;5(1):10942. doi: 10.1038/srep10942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Huang F, Guo J, Zou Z, Liu J, Cao B, Zhang S, Li H, Wang W, Sheng M, Liu S, Pan J, Bao C, Zeng M, Xiao H, Qian G, Hu X, Chen Y, Chen Y, Zhao Y, Liu Q, Zhou H, Zhu J, Gao H, Yang S, Liu X, Zheng S, Yang J, Diao H, Cao H, Wu Y, Zhao M, Tan S, Guo D, Zhao X, Ye Y, Wu W, Xu Y, Penninger JM, Li D, Gao GF, Jiang C, Li L. Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients. Nat Commun. 2014;5(1):3595. doi: 10.1038/ncomms4595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Liu B, Havers FP, Zhou L, Zhong H, Wang X, Mao S, Li H, Ren R, Xiang N, Shu Y, Zhou S, Liu F, Chen E, Zhang Y, Widdowson MA, Li Q, Feng Z. Clusters of human infections with avian influenza A (H7N9) virus in China, March 2013 to June 2015. J Infect Dis. 2017;216(suppl_4):S548–S554. doi: 10.1093/infdis/jix098. [DOI] [PubMed] [Google Scholar]
  • 46.Peiris JS, Cowling BJ, Wu JT, Feng L, Guan Y, Yu H, Leung GM. Interventions to reduce zoonotic and pandemic risks from avian influenza in Asia. Lancet Infect Dis. 2016;16(2):252–258. doi: 10.1016/S1473-3099(15)00502-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Gong Z, Lv H, Ding H, Han J, Sun J, Chai C, Cai J, Yu Z, Chen E. Epidemiology of the avian influenza A (H7N9) outbreak in Zhejiang Province, China. BMC Infect Dis. 2014;14(1):244. doi: 10.1186/1471-2334-14-244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Chen E, Wang MH, He F, Sun R, Cheng W, Zee BCY, Lau SYF, Wang X, Chong KC. An increasing trend of rural infections of human influenza A (H7N9) from 2013 to 2017: a retrospective analysis of patient exposure histories in Zhejiang Province, China. PLoS One. 2018;13(2):e0193052. doi: 10.1371/journal.pone.0193052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Rogers GN, Daniels RS, Skehel JJ, Wiley DC, Wang XF, Higa HH, Paulson JC. Host-mediated selection of influenza virus receptor variants. Sialic acid-α 2,6Gal-specific clones of A/duck/Ukraine/1/63 revert to sialic acid-α 2,3Gal-specific wild type in ovo. J Biol Chem. 1985;260(12):7362–7367. [PubMed] [Google Scholar]
  • 50.Ou X, Chen F, Zhang R, Chen J, Liu R, Sun B. Analysis of the full-length genome of a novel strain of the H7N9 avian influenza virus. Exp Ther Med. 2014;7(5):1369–1375. doi: 10.3892/etm.2014.1590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Liu Q, Zhou B, Ma W, Bawa B, Ma J, Wang W, Lang Y, Lyoo Y, Halpin RA, Lin X, Stockwell TB, Webby R, Wentworth DE, Richt JA. Analysis of recombinant H7N9 wild-type and mutant viruses in pigs shows that the Q226L mutation in HA is important for transmission. J Virol. 2014;88(14):8153–8165. doi: 10.1128/JVI.00894-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.de Vries RP, Peng W, Grant OC, Thompson AJ, Zhu X, Bouwman KM, de la Pena ATT, van Breemen MJ, Ambepitiya Wickramasinghe IN, de Haan CAM, Yu W, McBride R, Sanders RW, Woods RJ, Verheije MH, Wilson IA, Paulson JC. Three mutations switch H7N9 influenza to human-type receptor specificity. PLoS Pathog. 2017;13(6):e1006390. doi: 10.1371/journal.ppat.1006390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Wang D, Yang L, Gao R, Zhang X, Tan Y, Wu A, Zhu W, Zhou J, Zou S, Li X, Sun Y, Zhang Y, Liu Y, Liu T, Xiong Y, Xu J, Chen L, Weng Y, Qi X, Guo J, Li X, Dong J, Huang W, Zhang Y, Dong L, Zhao X, Liu L, Lu J, Lan Y, Wei H, Xin L, Chen Y, Xu C, Chen T, Zhu Y, Jiang T, Feng Z, Yang W, Wang Y, Zhu H, Guan Y, Gao GF, Li D, Han J, Wang S, Wu G, Shu Y. Genetic tuning of the novel avian influenza A(H7N9) virus during interspecies transmission, China, 2013. Euro Surveill. 2014;19(25):20836. doi: 10.2807/1560-7917.ES2014.19.25.20836. [DOI] [PubMed] [Google Scholar]
  • 54.Wan YH, Zhuang L, Zheng QN, Ren LJ, Fu L, Jiang WJ, Tang GP, Zhang DZ, Li SJ. Genetic characteristics of hemagglutinin and neuraminidase of avian influenza A (H7N9) virus in Guizhou Province, 2014–2017. Chin J Epidemiol (Zhonghua Liu Xing Bing Xue Za Zhi) 2018;39(11):1465–1471. doi: 10.3760/cma.j.issn.0254-6450.2018.11.009. [DOI] [PubMed] [Google Scholar]
  • 55.Qi X, An X, Jiao Y, Yu H, Xu K, Cui L, Wang S, Deng F, Huo X, Huang H, Dai Q, Bao C. Co-circulation of multiple genotypes of influenza A (H7N9) viruses in eastern China, 2016–2017. Arch Virol. 2018;163(7):1779–1793. doi: 10.1007/s00705-018-3800-3. [DOI] [PubMed] [Google Scholar]
  • 56.Li J, Yu X, Pu X, Xie L, Sun Y, Xiao H, Wang F, Din H, Wu Y, Liu D, Zhao G, Liu J, Pan J. Environmental connections of novel avianorigin H7N9 influenza virus infection and virus adaptation to the human. Sci China Life Sci. 2013;56(6):485–492. doi: 10.1007/s11427-013-4491-3. [DOI] [PubMed] [Google Scholar]
  • 57.Wong CK, Zhu H, Li OT, Leung YH, Chan MC, Guan Y, Peiris JS, Poon LL. Molecular detection of human H7N9 influenza A virus causing outbreaks in China. Clin Chem. 2013;59(7):1062–1067. doi: 10.1373/clinchem.2013.208975. [DOI] [PubMed] [Google Scholar]
  • 58.Ning T, Nie J, Huang W, Li C, Li X, Liu Q, Zhao H, Wang Y. Antigenic drift of influenza A (H7N9) virus hemagglutinin. J Infect Dis. 2019;219(1):19–25. doi: 10.1093/infdis/jiy408. [DOI] [PubMed] [Google Scholar]
  • 59.Chang P, Sealy JE, Sadeyen JR, Iqbal M. Amino acid residue 217 in the hemagglutinin glycoprotein is a key mediator of avian influenza H7N9 virus antigenicity. J Virol. 2018;93(1):e01627–18. doi: 10.1128/JVI.01627-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Zou X, Guo Q, Zhang W, Chen H, Bai W, Lu B, Zhang W, Fan Y, Liu C, Wang Y, Zhou F, Cao B, Community-acquired Pneumonia-China Network Dynamic variation and reversion in the signature amino acids of H7N9 virus during human infection. J Infect Dis. 2018;218(4):586–594. doi: 10.1093/infdis/jiy217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Dong Z, Xia Y, Ya X, Chen L, Liu C, Wang R, Shen Q. Epidemiological and genetic characteristics of the fifth avian influenza A (H7N9) wave in Suzhou, China, from October 2016 to April 2017. Virus Genes. 2018;54(2):182–189. doi: 10.1007/s11262-018-1534-7. [DOI] [PubMed] [Google Scholar]
  • 62.Marjuki H, Mishin VP, Chesnokov AP, De La Cruz JA, Davis CT, Villanueva JM, Fry AM, Gubareva LV. Neuraminidase mutations conferring resistance to oseltamivir in influenza A(H7N9) viruses. J Virol. 2015;89(10):5419–5426. doi: 10.1128/JVI.03513-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Marjuki H, Mishin VP, Chesnokov AP, Jones J, De La Cruz JA, Sleeman K, Tamura D, Nguyen HT, Wu HS, Chang FY, Liu MT, Fry AM, Cox NJ, Villanueva JM, Davis CT, Gubareva LV. Characterization of drug-resistant influenza A (H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. J Infect Dis. 2015;211(2):249–257. doi: 10.1093/infdis/jiu447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Yiu Lai K, Wing Yiu Ng G, Fai Wong K, Fan Ngai Hung I, Kam Fai Hong J, Fan Cheng F, Kwok Cheung Chan J. Human H7N9 avian influenza virus infection: a review and pandemic risk assessment. Emerg Microbes Infect. 2013;2(8):e48. doi: 10.1038/emi.2013.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Shi J, Deng G, Kong H, Gu C, Ma S, Yin X, Zeng X, Cui P, Chen Y, Yang H, Wan X, Wang X, Liu L, Chen P, Jiang Y, Liu J, Guan Y, Suzuki Y, Li M, Qu Z, Guan L, Zang J, Gu W, Han S, Song Y, Hu Y, Wang Z, Gu L, Yang W, Liang L, Bao H, Tian G, Li Y, Qiao C, Jiang L, Li C, Bu Z, Chen H. H7N9 virulent mutants detected in chickens in China pose an increased threat to humans. Cell Res. 2017;27(12):1409–1421. doi: 10.1038/cr.2017.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Li W, Lee HHY, Li RF, Zhu HM, Yi G, Peiris JSM, Yang ZF, Mok CKP. The PB2 mutation with lysine at 627 enhances the pathogenicity of avian influenza (H7N9) virus which belongs to a non-zoonotic lineage. Sci Rep. 2017;7(1):2352. doi: 10.1038/s41598-017-02598-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Chen GW, Kuo SM, Yang SL, Gong YN, Hsiao MR, Liu YC, Shih SR, Tsao KC. Genomic signatures for avian H7N9 viruses adapting to humans. PLoS One. 2016;11(2):e0148432. doi: 10.1371/journal.pone.0148432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Chan LL, Bui CT, Mok CK, Ng MM, Nicholls JM, Peiris JS, Chan MC, Chan RW. Evaluation of the human adaptation of influenza A/H7N9 virus in PB2 protein using human and swine respiratory tract explant cultures. Sci Rep. 2016;6(1):35401. doi: 10.1038/srep35401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Mok CK, Lee HH, Lestra M, Nicholls JM, Chan MC, Sia SF, Zhu H, Poon LL, Guan Y, Peiris JS. Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts. J Virol. 2014;88(6):3568–3576. doi: 10.1128/JVI.02740-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Deng Y, Li C, Han J, Wen Y, Wang J, Hong W, Li X, Liu Z, Ye Q, Li J, Zhou C, Yu L, Qin C, Zhang F, Jiang T. Phylogenetic and genetic characterization of a 2017 clinical isolate of H7N9 virus in Guangzhou, China during the fifth epidemic wave. Sci China Life Sci. 2017;60(12):1331–1339. doi: 10.1007/s11427-017-9152-1. [DOI] [PubMed] [Google Scholar]
  • 71.Fries LF, Smith GE, Glenn GM. A recombinant viruslike particle influenza A (H7N9) vaccine. N Engl J Med. 2013;369(26):2564–2566. doi: 10.1056/NEJMc1313186. [DOI] [PubMed] [Google Scholar]
  • 72.Bart SA, Hohenboken M, Della Cioppa G, Narasimhan V, Dormitzer PR, Kanesa-Thasan N. A cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adults. Sci Transl Med. 2014;6(234):234ra55. doi: 10.1126/scitranslmed.3008761. [DOI] [PubMed] [Google Scholar]
  • 73.Mulligan MJ, Bernstein DI, Winokur P, Rupp R, Anderson E, Rouphael N, Dickey M, Stapleton JT, Edupuganti S, Spearman P, Ince D, Noah DL, Hill H, Bellamy AR, DMID 13-0032 H7N9 Vaccine Study Group Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial. JAMA. 2014;312(14):1409–1419. doi: 10.1001/jama.2014.12854. [DOI] [PubMed] [Google Scholar]
  • 74.Jackson LA, Campbell JD, Frey SE, Edwards KM, Keitel WA, Kotloff KL, Berry AA, Graham I, Atmar RL, Creech CB, Thomsen IP, Patel SM, Gutierrez AF, Anderson EL, El Sahly HM, Hill H, Noah DL, Bellamy AR. Effect of varying doses of a monovalent H7N9 influenza vaccine with and without AS03 and MF59 adjuvants on immune response: a randomized clinical trial. JAMA. 2015;314(3):237–246. doi: 10.1001/jama.2015.7916. [DOI] [PubMed] [Google Scholar]
  • 75.Madan A, Segall N, Ferguson M, Frenette L, Kroll R, Friel D, Soni J, Li P, Innis BL, Schuind A. Immunogenicity and safety of an AS03-adjuvanted H7N9 pandemic influenza vaccine in a randomized trial in healthy adults. J Infect Dis. 2016;214(11):1717–1727. doi: 10.1093/infdis/jiw414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Rudenko L, Isakova-Sivak I, Naykhin A, Kiseleva I, Stukova M, Erofeeva M, Korenkov D, Matyushenko V, Sparrow E, Kieny MP. H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2016;16(3):303–310. doi: 10.1016/S1473-3099(15)00378-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Wu UI, Hsieh SM, Lee WS, Wang NC, Kung HC, Ou TY, Chen FL, Lin TY, Chen YC, Chang SC. Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: a phase I/II, prospective, randomized, open-label trial. Vaccine. 2017;35(33):4099–4104. doi: 10.1016/j.vaccine.2017.06.044. [DOI] [PubMed] [Google Scholar]
  • 78.Wu J, Ke C, Lau EHY, Song Y, Cheng KL, Zou L, Kang M, Song T, Peiris M, Yen HL. Influenza H5/H7 virus vaccination in poultry and reduction of zoonotic infections, Guangdong Province, China, 2017–18. Emerg Infect Dis. 2019;25(1):116–118. doi: 10.3201/eid2501.181259. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

11684_2020_739_MOESM1_ESM.pdf (163.4KB, pdf)

Supplementary material, approximately 163 KB.

Articles from Frontiers of Medicine are provided here courtesy of Nature Publishing Group

RESOURCES